John Zhao-Nian Lu

Title: Innovations of John Zhao-Nian Lu

Introduction

John Zhao-Nian Lu is a notable inventor based in Alhambra, CA (US). He has made significant contributions to the field of cancer treatment, particularly in ovarian cancer therapies. With a total of 2 patents, his work focuses on innovative methods to improve patient outcomes.

Latest Patents

One of his latest patents involves the administration of an anti-activin-A compound to a subject. This invention relates to methods of treating ovarian cancer by evaluating the subject's expression levels of specific biomarkers or angiogenic factors. The patent describes the administration of an anti-activin-A compound, such as an anti-activin-A antibody or an activin-A-binding receptor. In some embodiments, at least two compounds are administered, where the first is an anti-activin A compound and the second is a chemotherapeutic compound, such as capecitabine. This invention also includes methods for identifying subjects suitable for treatment.

Career Highlights

Throughout his career, John has worked with prominent companies in the biotechnology sector. He has been associated with Atara Biotherapeutics, Inc. and Amgen Inc., where he has contributed to various research and development projects aimed at advancing therapeutic solutions.

Collaborations

John has collaborated with several professionals in his field, including Huiquan Han and Christopher Haqq. These collaborations have further enhanced his research and innovation efforts.

Conclusion

John Zhao-Nian Lu's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work continues to influence the field of oncology and offers hope for better treatment options for patients.